CRISPR
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk
LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2.
As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit.
Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests
The agreements will increase access to testing in Asia through United PPE and in the Middle East through Cooper International, the foundation said.
DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.